LiveRamp (RAMP) Upgraded to Strong Buy: Here's Why

LiveRamp (RAMP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting a significant 27.1% increase in its Zacks Consensus Earnings Estimate over the past three months for the fiscal year ending March 2026. This upgrade signals an improving earnings outlook, which, according to the Zacks rating system, strongly correlates with near-term stock price movements and indicates potential for appreciation, given the historical outperformance of Zacks Rank #1 stocks.

Analysis

LiveRamp (RAMP) has been upgraded to a Zacks Rank #1 (Strong Buy), a rating based on positive revisions to its earnings estimates. This upgrade is quantitatively driven by a significant 27.1% increase in the Zacks Consensus Estimate for the fiscal year ending March 2026 over the past three months. According to the rating methodology, such upward revisions are a strong leading indicator of near-term stock appreciation, as institutional investors often adjust valuation models and increase positions based on an improved earnings outlook. However, it is critical to note that the projected earnings of $2.28 per share for fiscal 2026 are reported as being unchanged from the prior year's figure. This suggests that while analyst sentiment and earnings expectations have improved substantially from previous levels, the current consensus does not forecast actual year-over-year earnings growth for that period, a nuance that warrants careful consideration against the bullish revision trend.

Key Decisions for Investors

• Investors may consider this upgrade a positive signal for near-term price momentum, given the strong historical correlation between Zacks Rank #1 ratings and stock performance.
• It is crucial to investigate the discrepancy between the 27.1% rise in consensus estimates and the flat year-over-year EPS projection for fiscal 2026, as this could imply that improved expectations are relative to prior pessimism rather than signaling new fundamental growth.
• Monitor upcoming earnings releases to see if the positive estimate revisions translate into accelerated revenue growth or margin expansion, which would be necessary to justify a sustained re-rating of the stock.